EFSA issues scientific opinion on safety of Cognis’ Tonalin CLA as a food ingredient
Cognis announced that the European Food Safety Authority (EFSA) concludes that the safety of Tonalin® CLA has been established for defined uses as a food ingredient. The EFSA scientific opinion marks a major step to gaining novel food approval for Tonalin® CLA in Europe.
Cognis was the first company in Europe to seek novel food approval for CLA, and the EFSA safety opinion is a necessary step towards obtaining it. In the next and final step of the approval process, the European Commission will present a draft decision to the Standing Committee on the Food Chain and Animal Health, which will make a final decision on the application. Tonalin® CLA has already been granted FDA GRAS status in the US for multiple food applications. It is also the only CLA to achieve novel food approval in China, making it the only product of its kind authorized for use in food products for the rapidly growing Chinese market. In addition, Cognis has recently enhanced Tonalin® CLA’s taste and sensory properties by incorporating an additional purification step during manufacturing.
BASF successfully completed its acquisition of Cognis Holding GmbH from Cognis Holding Luxembourg S.à r.l. controlled by Permira Funds, GS Capital Partners and SV Life Sciences on December 9, 2010. The equity purchase price was €700 million. Including net financial debt and pension obligati ... more
Cognis presented its internal Innovation Award for the tenth year. The award recognizes the creative thinking and outstanding achievements of the four winning teams. All of them were responsible for exceptionally innovative and successful projects that improved the sustainability and perfor ... more
The European Commission approved the acquisition of Cognis Holding GmbH by BASF SE. The approval is subject to the divestiture of businesses that accounted for sales of significantly less than €100 million, which is less than 3% of Cognis’ total sales. In addition, the Chinese authorities a ... more
EFSA is currently involved in a number of initiatives to develop scientific knowledge in the field of endocrine active substances and also on overlapping issues such as non-monotonic dose-response relationships and biological relevance in risk assessment. This work follows up on a 2013 scie ... more
EFSA’s comprehensive re-evaluation of bisphenol A (BPA) exposure and toxicity concludes that BPA poses no health risk to consumers of any age group (including unborn children, infants and adolescents) at current exposure levels. Exposure from the diet or from a combination of sources (diet, ... more
EFSA has confirmed previous evaluations that, based on animal studies, acrylamide in food potentially increases the risk of developing cancer for consumers in all age groups. Acrylamide in food is produced by the same chemical reaction that “browns” food – also making it tastier – during ev ... more
Representatives from the scientific and risk assessment community as well as risk managers from in and outside Europe are invited to attend a major scientific conference organised by EFSA on the occasion of the World EXPO 2015.
The objectives of this conference are to take stock of the cha ... more